Cic edizioni internazionali
Il Giornale di Chirurgia

Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance

Review, 225 - 235
doi: 10.11138/gchir/2016.37.5.225
Tag this article
Abstract
Enhanced HTML Full text PDF
Conventional therapeutic approaches for advanced prostate cancer - such as androgen deprivation, chemotherapy, radiation - come up often against lack of effectiveness because of possible arising of correlative cancer cell resistance and/or inadequate anti-tumor immune conditions.
Whence the timeliness of resorting to immune-based treatment strategies including either therapeutic vaccination-based active immunotherapy or anti-tumor monoclonal antibody-mediated passive immunotherapy.
Particularly attractive, as for research studies and clinical applications, results to be the cytotoxic T-lymphocyte check point blockade by the use of anti-CTLA-4 and PD-1 monoclonal antibodies, particularly when combined with androgen deprivation therapy or radiation. Unlike afore said immune check point inhibitors, both cell-based (by the use of prostate specific antigen carriers autologous dendritic cells or even whole cancer cells) and recombinant viral vector vaccines are able to induce immune-mediated focused killing of specific antigen-presenting prostate cancer cells. Such vaccines, either used alone or concurrently/sequentially combined with above-mentioned conventional therapies, led to generally reach, in the field of various clinical trials, reasonable results particularly as regards the patient's overall survival. Adoptive trasferred T-cells, as adoptive T-cell passive immunotherapy, and monoclonal antibodies against specific antigen-endowed prostate cancer cells can improve immune micro-environmental conditions. On the basis of a preliminary survey about various immunotherapy strategies, are here also outlined their effects when combined with androgen deprivation therapy or radiation. What's more, as regard the immune-based treatment effectiveness, it has to be pointed out that suitable personalized epigenetic/gene profile-achieved pharmacogenomic approaches to target identified gene aberrations, may lead to overcome – as well as for conventional therapies – possible prostate cancer resistance to immunotherapy.

Vol. XXXVIII (No. 3) 2017 May - June

  1. A neurological disease on the face of an ancient Roman sculpture
    Baggieri G., Galieti L.
    doi: 10.11138/gchir/2017.38.3.115
  2. Autologous fat transplantation for secondary breast reconstruction: our experience
    Simonacci F., Grieco M.P., Bertozzi N., Raposio E.
    doi: 10.11138/gchir/2017.38.3.117
  3. Deep spinal infection in instrumented spinal surgery: diagnostic factors and therapy
    Dobran M., Marini A., Gladi M., Nasi D., Colasanti R., Benigni R., Mancini F., Iacoangeli M., Scerrati M.
    doi: 10.11138/gchir/2017.38.3.124
  4. Necrotizing fasciitis associated with primary cutaneous B-cell lymphoma. A case report
    Spiridakis K.G., Intzepogazoglou D.S., Flamourakis M.E., Sfakianakis E.E., Daskalaki A.V., Vakonaki E.K.., Rahmanis E., Kostakis G.E., Christodoulakis M.S.
    doi: 10.11138/gchir/2017.38.3.130
  5. Epidural abscess imitating recurrent pilonidal sinus: a case report
    Koutserimpas C., Nikitakis N., Skarpas A., Lada M., Papachristou E., Velimezis G.
    doi: 10.11138/gchir/2017.38.3.135
  6. Primitive squamous cell carcinoma of the breast (SCCB): case report of an uncommon variant of metaplastic carcinoma
    Punzo C., Fortarezza F., De Ruvo V., Minafra M., Laforgia R., Casamassima G., Pezzuto F., Punzi A., Caporusso C., Angelelli G., Palasciano N.
    doi: 10.11138/gchir/2017.38.3.139
  7. Polythelia in a 13-year old girl
    Halleland H.H., Balling E., Tei T., Arcieri S., Mertz H., Mele M.
    doi: 10.11138/gchir/2017.38.3.143
  8. Primary intestinal choriocarcinoma in a patient with long-standing Crohn’s disease
    Pezzuto F., Fortarezza F., Falcone V., Quintiliani C., Piscitelli D.
    doi: 10.11138/gchir/2017.38.3.147
  9. Medico legal aspects on neuromonitoring in thyroid surgery: informed consent on malpractice claims
    Demontis R., Pittau M.R., Maturo A., Petruzzo P., Calò G.
    doi: 10.11138/gchir/2017.38.3.149
  10. ATLAS OF ANATOMY, Latin nomenclature (3rd edition)
    Di Matteo G.
  11. III CONGRESSO NAZIONALE S.I.C.U.T. DI PRIMAVERA La Chirurgia d’Urgenza e del Trauma Italiana nei contesti di maxiemergenza
    Di Matteo G.
Last Viewed articles: la lista degli ultimi x visitati.
  1. Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance
    Alberti C.
    doi: 10.11138/gchir/2016.37.5.225
credits